Home » Topics » BioWorld

BioWorld
RSS

HAMBRECHT AND QUIST CONFERENCE

Jan. 11, 1991

SOME PEPTIDE VACCINES MAY BOOST INFECTION

Jan. 11, 1991

KANSAS-BOUND BIOTECHNICA TO SELL UNITS

Jan. 10, 1991

BIOREMEDIATION WASTE CONTROL MORE PROMISING

Jan. 10, 1991

APPOINTMENTS AND ADVANCEMENTS

Jan. 10, 1991

BIOREMEDIATION, Part 2

Jan. 10, 1991

NEWS BRIEFS

Jan. 10, 1991

DNX, GENPHARM SIGN CROSS-LICENSE

Jan. 10, 1991

ECOGEN SIGNS R AND D DEAL WITH ROUSSEL

Jan. 10, 1991

HAMBRECHT AND QUIST CONFERENCE

Jan. 10, 1991

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...